Table 3.
Hierarchical multiple linear regressions examining the effects of drug user type, psychopathic personality features, and “hot” neurocognitive impulsivity on sexual risk behavior.
| Past 30-day Sexual Risk Behaviors
|
Past 6-month Sexual Risk Behaviors
|
Lifetime Sexual Risk Behaviors
|
||||
|---|---|---|---|---|---|---|
| ΔR2 | β | ΔR2 | β | ΔR2 | β | |
|
|
|
|
||||
| Step 1: Control Variables | .02 | .04 | .16** | |||
| Step 2: Drug User Groups | .04 | .04* | .13** | |||
| Amphetamine | .08 | .12 | .29** | |||
| Heroin | .22* | .25** | .36** | |||
| Polysubstance | .02 | .14 | .31** | |||
| Step 3: Main Effects of Psychopathy and “Hot” Impulsivity Composite | .04* | .07** | .06** | |||
| PCL:SV | .12 | .32** | .32** | |||
| “Hot” Impulsivity | .16* | .07 | −.06 | |||
| Step 4: Drug User Group Interactions with Psychopathy and “Hot” Impulsivity Composite | .08** | .06* | .05* | |||
| Amphetamine × PCL:SV | −.31 | −.32 | −.34* | |||
| Amphetamine × “Hot” Impulsivity | .04 | −.002 | .02 | |||
| Heroin × PCL:SV | −.01 | −.39 | −.33 | |||
| Heroin × Hot” Impulsivity | −.13 | −.06 | −.05 | |||
| Polysubstance × PCL:SV | −.48* | −.67** | −.61** | |||
| Polysubstance × Hot” Impulsivity | −.18* | −.08 | −.04 | |||
Note.
p ≤ .05;
p < .01;
PCL:SV = Psychopathy Checklist: Screening Version